Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 7 (July)

1. A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder.
   Int J Geriatr Psychiatry, 23(7): 693-8. [Abstract] [Full-text]
2. Perceptual switch rates with ambiguous structure-from-motion figures in bipolar disorder.
   Proc Biol Sci, 275(1645): 1839-48. [Abstract] [Full-text]
3. Substance use disorders and suicide attempts in bipolar subtypes.
   J Psychiatr Res. [Abstract] [Full-text]
4. Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity.
   Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
5. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder.
   Expert Rev Neurother, 8(7): 1101-13. [Abstract] [Full-text]
6. Wandering behavior in veterans with psychiatric diagnoses residing in nursing homes.
   Int J Geriatr Psychiatry, 23(7): 748-53. [Abstract] [Full-text]
7. Prevalence and correlates of shoplifting in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
   Am J Psychiatry, 165(7): 905-13. [Abstract] [Full-text]
8. Genetic-linkage mapping of complex hereditary disorders to a whole-genome molecular-interaction network.
   Genome Res, 18(7): 1150-62. [Abstract] [Full-text]
9. Sleep disturbance in bipolar disorder: therapeutic implications.
   Am J Psychiatry, 165(7): 830-43. [Abstract] [Full-text]
10. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation.
    Am J Psychiatry, 165(7): 820-9. [Abstract] [Full-text]
11. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    J Affect Disord, 109(3): 251-263. [Abstract] [Full-text]
12. Dysthymic and anxiety-related personality traits in bipolar spectrum illness.
    J Affect Disord, 109(3): 305-11. [Abstract] [Full-text]
13. Delirious mania: Clinical features and treatment response.
    J Affect Disord, 109(3): 312-6. [Abstract] [Full-text]
14. Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania.
    Biol Psychiatry. [Abstract] [Full-text]
15. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    J Affect Disord, 109(3): 286-99. [Abstract] [Full-text]
16. Association study of Wnt signaling pathway genes in bipolar disorder.
    Arch Gen Psychiatry, 65(7): 785-93. [Abstract] [Full-text]
17. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis.
    Arch Gen Psychiatry, 65(7): 746-60. [Abstract] [Full-text]
18. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.
    Cancer Lett. [Abstract] [Full-text]
19. Prevention of bipolar disorder in at-risk children: theoretical assumptions and empirical foundations.
    Dev Psychopathol, 20(3): 881-97. [Abstract] [Full-text]
20. Stressful life events in older bipolar patients.
    Int J Geriatr Psychiatry. [Abstract] [Full-text]
21. Alert: inaccurate lithium assay results.
    Aust N Z J Psychiatry, 42(7): 643-5. [Abstract] [Full-text]
22. Estimating intracellular lithium in brain in vivo by localized 7Li magnetic resonance spectroscopy.
    Magn Reson Med, 60(1): 21-6. [Abstract] [Full-text]
23. Quetiapine-associated dysphagia.
    World J Biol Psychiatry. [Abstract] [Full-text]
24. Revised Korean medication algorithm for bipolar disorder.
    World J Biol Psychiatry. [Abstract] [Full-text]
25. Anomalous dopamine release associated with a human dopamine transporter coding variant.
    J Neurosci, 28(28): 7040-6. [Abstract] [Full-text]
26. Correlates of insider and outsider conceptualizations of recovery.
    Psychiatr Rehabil J, 32(1): 23-31. [Abstract] [Full-text]
27. Understanding How Clinician-Patient Relationships and Relational Continuity of Care Affect Recovery from Serious Mental Illness: STARS Study Results.
    Psychiatr Rehabil J, 32(1): 9-22. [Abstract] [Full-text]
28. Variation in the purinergic P2RX(7) receptor gene and schizophrenia.
    Schizophr Res. [Abstract] [Full-text]
29. Predicting lifetime mood elevation in primary care patients and psychiatric patients.
    Nord J Psychiatry. [Abstract] [Full-text]
30. Primary leptomeningeal B-cell lymphoma of MALT-type in statu nascendi: A case report and review of the literature.
    Clin Neurol Neurosurg, 110(7): 732-738. [Abstract] [Full-text]
31. Functional brain abnormalities in psychiatric disorders: Neural mechanisms to detect and resolve cognitive conflict and interference.
    Brain Res Rev. [Abstract] [Full-text]
32. Abnormal Corpus Callosum Integrity in Bipolar Disorder: A Diffusion Tensor Imaging Study.
    Biol Psychiatry. [Abstract] [Full-text]
33. Social dysfunction in bipolar disorder: pilot study.
    Aust N Z J Psychiatry, 42(8): 686-92. [Abstract] [Full-text]
34. Abnormal reward system activation in mania.
    Neuropsychopharmacology, 33(9): 2217-27. [Abstract] [Full-text]
35. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
    Neuropsychopharmacology, 33(9): 2175-86. [Abstract] [Full-text]
36. Novel drugs and therapeutic targets for severe mood disorders.
    Neuropsychopharmacology, 33(9): 2080-92. [Abstract] [Full-text]
37. Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: Evidence for lack of monoaminergic association.
    J Neurosci Res. [Abstract] [Full-text]
38. Quality of Care for Cardiovascular Disease-related Conditions in Patients with and without Mental Disorders.
    J Gen Intern Med. [Abstract] [Full-text]
39. Service user perspectives of a psychoeducation group for individuals with a diagnosis of bipolar disorder: a qualitative study.
    J Nerv Ment Dis, 196(7): 568-71. [Abstract] [Full-text]
40. Brain Lithium Levels and Effects on Cognition and Mood in Geriatric Bipolar Disorder: A Lithium-7 Magnetic Resonance Spectroscopy Study.
    Am J Geriatr Psychiatry. [Abstract] [Full-text]
41. The Safety of the Electroconvulsive Therapy-Escitalopram Combination.
    J ECT. [Abstract] [Full-text]
42. Analysis of BDNF Val66Met allele-specific mRNA levels in bipolar disorder.
    Neurosci Lett, 441(2): 229-32. [Abstract] [Full-text]
43. Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.
    J Clin Psychopharmacol, 28(4): 441-6. [Abstract] [Full-text]
44. The role of family functioning in bipolar disorder in families.
    J Abnorm Child Psychol, 36(6): 849-63. [Abstract] [Full-text]
45. Association study between genetic variants at the VAMP2 and VAMP3 loci and bipolar affective disorder.
    Psychiatr Genet, 18(4): 199-203. [Abstract] [Full-text]
46. Genome-wide parametric linkage analyses of 644 bipolar pedigrees suggest susceptibility loci at chromosomes 16 and 20.
    Psychiatr Genet, 18(4): 191-8. [Abstract] [Full-text]
47. Genome screen of 15 Australian bipolar affective disorder pedigrees supports previously identified loci for bipolar susceptibility genes.
    Psychiatr Genet, 18(4): 156-61. [Abstract] [Full-text]
48. Region-of-interest-based analysis with application of cortical thickness variation of left planum temporale in schizophrenia and psychotic bipolar disorder.
    Hum Brain Mapp, 29(8): 973-85. [Abstract] [Full-text]
49. Two structurally distinct inhibitors of glycogen synthase kinase 3 induced centromere positive micronuclei in human lymphoblastoid TK6 cells.
    Mutat Res. [Abstract] [Full-text]
50. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
    Ann Clin Psychiatry, 20(3): 139-44. [Abstract] [Full-text]
51. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder.
    Ann Clin Psychiatry, 20(3): 131-7. [Abstract] [Full-text]
52. Long-term outcomes of youth who manifested the CBCL-Pediatric Bipolar Disorder phenotype during childhood and/or adolescence.
    J Affect Disord. [Abstract] [Full-text]
53. Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials.
    J Psychopharmacol. [Abstract] [Full-text]
54. The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions.
    Mol Psychiatry, 13(8): 742-71. [Abstract] [Full-text]
55. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Neuroscience. [Abstract] [Full-text]
56. A prospective study of patients absconding from a general hospital psychiatry unit in a developing country.
    J Psychiatr Ment Health Nurs, 15(6): 458-64. [Abstract] [Full-text]
57. Circadian phenotype in patients with the co-morbid alcohol use and bipolar disorders.
    Alcohol Alcohol. [Abstract] [Full-text]
58. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia.
    Schizophr Res, 103(1): 192-200. [Abstract] [Full-text]
59. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder.
    Schizophr Res, 103(1): 186-91. [Abstract] [Full-text]
60. An auditory processing abnormality specific to liability for schizophrenia.
    Schizophr Res, 103(1): 298-310. [Abstract] [Full-text]
61. A role for the circadian genes in drug addiction.
    Neuropharmacology. [Abstract] [Full-text]
62. Brain oscillatory responses in patients with bipolar disorder manic episode before and after valproate treatment.
    Brain Res. [Abstract] [Full-text]
63. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in bipolar disorder.
    Acta Psychiatr Scand. [Abstract] [Full-text]
64. Clinically relevant safety issues associated with St. John's wort product labels.
    BMC Complement Altern Med, 8: 42. [Abstract] [Full-text]
65. Differential effect of carbamazepine and oxcarbazepine on excitatory synaptic transmission in rat hippocampus.
    Synapse, 62(10): 783-789. [Abstract] [Full-text]
66. Practice of electroconvulsive therapy at the research and training hospital in Turkey.
    Soc Psychiatry Psychiatr Epidemiol, 43(8): 673-7. [Abstract] [Full-text]
67. Stability and treatment outcome of distinct classes of mania.
    Eur Psychiatry, 23(5): 360-7. [Abstract] [Full-text]
68. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
69. Gender influences the detection of spatial working memory deficits in bipolar disorder.
    Bipolar Disord, 10(5): 647-54. [Abstract] [Full-text]
70. Appreciation of research information in patients with bipolar disorder.
    Bipolar Disord, 10(5): 635-46. [Abstract] [Full-text]
71. Quality of life in bipolar disorder patients: a comparison with a general population sample.
    Bipolar Disord, 10(5): 625-34. [Abstract] [Full-text]
72. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Bipolar Disord, 10(5): 617-24. [Abstract] [Full-text]
73. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Bipolar Disord, 10(5): 607-16. [Abstract] [Full-text]
74. Rapid switching of mood in families with familial bipolar disorder.
    Bipolar Disord, 10(5): 597-606. [Abstract] [Full-text]
75. Differences in incidence of suicide attempts during phases of bipolar I and II disorders.
    Bipolar Disord, 10(5): 588-96. [Abstract] [Full-text]
76. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene.
    Bipolar Disord, 10(5): 580-7. [Abstract] [Full-text]
77. Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change.
    Bipolar Disord, 10(5): 566-79. [Abstract] [Full-text]
78. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
    J Affect Disord. [Abstract] [Full-text]
79. A systematic review of off-label uses of memantine for psychiatric disorders.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(6): 1362-74. [Abstract] [Full-text]
80. TNF-alpha as a molecular target in bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(6): 1355-61. [Abstract] [Full-text]
81. Mood stabilizing drugs expand the neural stem cell pool in the adult brain through activation of notch signaling.
    Stem Cells, 26(7): 1758-67. [Abstract] [Full-text]
82. Are neuropsychological deficits trait markers in OCD?
    Prog Neuropsychopharmacol Biol Psychiatry, 32(6): 1574-9. [Abstract] [Full-text]
83. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(6): 1501-7. [Abstract] [Full-text]
84. Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder.
    J Neural Transm. [Abstract] [Full-text]
85. Brain-Derived Neurotrophic Factor Gene Expression in Pediatric Bipolar Disorder: Effects of Treatment and Clinical Response.
    J Am Acad Child Adolesc Psychiatry. [Abstract] [Full-text]
86. Do risk factors for suicidal behavior differ by affective disorder polarity?
    Psychol Med. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.